Leptin Neutralizing Antibody Detection via Labeled Leptin Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a reliable method to detect neutralizing antibodies to metreleptin in subjects, as these antibodies can render metreleptin treatment ineffective and worsen leptin deficiency-related disorders.
Innovation Solution
A method involving the inactivation of leptin in a sample, followed by the addition of labeled leptin, which is then bound to a substrate capable of binding leptin. The sample is washed to remove unbound labeled leptin, and the label signal is measured to determine the presence of neutralizing antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If repeated metreleptin administration is performed, then treatment effectiveness is maintained, but neutralizing antibodies develop that render treatment ineffective
Solution Approach 1:
The patent applies preliminary action by detecting neutralizing antibodies before they completely eliminate treatment effectiveness. The assay method enables early detection of antibody development, allowing clinicians to identify at-risk patients before treatment failure occurs, thus maintaining treatment reliability through timely intervention
2Reliability
If neutralizing antibodies are detected, then treatment effectiveness can be maintained by adjusting therapy, but detection methods must be highly reliable
Solution Approach 1:
The patent applies the extraction principle by isolating and measuring only the neutralizing antibody component that interferes with leptin binding. The assay specifically extracts this harmful element from the complex biological sample, enabling precise measurement of neutralizing activity without interference from other antibodies or proteins
Solution Approach 2:
The patent uses an intermediary approach by introducing a labeled leptin analog as a mediator between the neutralizing antibodies and the detection system. This intermediary molecule allows indirect but highly specific measurement of neutralizing antibody activity through its binding interaction, achieving high measurement precision
3Measurement precision
If a reliable detection method is implemented, then subjects who do not respond to therapy can be identified, but the detection process becomes more complex
Solution Approach 1:
The patent applies universality by designing an assay system that can detect neutralizing antibodies across different patient populations and clinical scenarios using a single standardized methodology. The leptin-based detection platform serves multiple functions: diagnosing treatment failure, monitoring antibody development over time, and potentially guiding therapeutic decisions
Solution Approach 2:
The patent uses parameter changes by varying the label type (fluorescent, enzymatic, radioactive) and substrate characteristics to optimize detection sensitivity and specificity for different clinical needs. By changing these parameters, the same basic assay principle can achieve high measurement precision while adapting to different laboratory capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the accurate detection of neutralizing antibodies to leptin, enabling healthcare providers to identify subjects who may not respond to leptin therapy and potentially adjust treatment accordingly.
Implementation Method 1
contacting the sample containing labeled leptin of (b) with a substrate capable of binding the labeled leptin
Data Source
AI summary
Provided herein are methods for detecting neutralizing antibodies to leptins, including metreleptin, as well as identifying subjects having such neutralizing antibodies.